BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12569360)

  • 1. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
    Funakoshi T; Tachibana I; Hoshida Y; Kimura H; Takeda Y; Kijima T; Nishino K; Goto H; Yoneda T; Kumagai T; Osaki T; Hayashi S; Aozasa K; Kawase I
    Oncogene; 2003 Feb; 22(5):674-87. PubMed ID: 12569360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
    Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
    Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of CD151 gene expression in non-small cell lung cancer.
    Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
    Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.
    Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M
    Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
    Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
    Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
    Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
    Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
    Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
    Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
    Salgia R; Li JL; Ewaniuk DS; Wang YB; Sattler M; Chen WC; Richards W; Pisick E; Shapiro GI; Rollins BJ; Chen LB; Griffin JD; Sugarbaker DJ
    Oncogene; 1999 Jan; 18(1):67-77. PubMed ID: 9926921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.
    Gesierich S; Paret C; Hildebrand D; Weitz J; Zgraggen K; Schmitz-Winnenthal FH; Horejsi V; Yoshie O; Herlyn D; Ashman LK; Zöller M
    Clin Cancer Res; 2005 Apr; 11(8):2840-52. PubMed ID: 15837731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF; Campbell SE; Bochner BS; Dang CV
    Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin.
    Okochi H; Kato M; Nashiro K; Yoshie O; Miyazono K; Furue M
    Br J Dermatol; 1997 Dec; 137(6):856-63. PubMed ID: 9470900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID mice.
    Zheng R; Yano S; Zhang H; Nakataki E; Tachibana I; Kawase I; Hayashi S; Sone S
    Oncol Res; 2005; 15(7-8):365-72. PubMed ID: 16491954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells.
    Saito Y; Tachibana I; Takeda Y; Yamane H; He P; Suzuki M; Minami S; Kijima T; Yoshida M; Kumagai T; Osaki T; Kawase I
    Cancer Res; 2006 Oct; 66(19):9557-65. PubMed ID: 17018612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas.
    Manda R; Kohno T; Niki T; Yamada T; Takenoshita S; Kuwano H; Yokota J
    Biochem Biophys Res Commun; 2000 Aug; 275(2):440-5. PubMed ID: 10964684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM; Webster SJ; Flower D; Woll PJ
    Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
    Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
    Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A; Lamb PW; Barrett JC
    Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.